Archive - April 2021
GW Pharma’s Epidyolex scores new EU indication
J&J resumes roll-out of COVID-19 vaccine in EU
Novartis’ MS therapy Kesimpta wins NICE backing
UK government launches search for at-home COVID-19 treatments
bluebird bio anticipates lift of clinical holds on LentiGlobin in mid-2021
WHO director-general says pandemic can be brought under control within months
NICE sets out plans for ‘ambitious’ five-year strategy
Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer